On March 18, 2017, 2016 Annual Conference and Third Meeting of Sixth Council of China Association for Medical Devices Industry was held in Beijing This meeting included two sessions: the annual conference and drug administration meeting. The deputy head of NDRC Price Supervision & Anti-Monopoly Bureau Li Qing, the chief of Machinery Division of MIIT Equipment Industry Department Zhao Fengjie, the deputy chief of CFIE Economic Organization Department Yan Yan, the director of NHDRC Medical Policy Research Office Fu Hongpeng and relevant staff of Medical Insurance Department of MOHRSS Social Insurance Center attended the annual conference. The annual conference was presided by Xu Shan, the deputy secretary-general of CAMDI. Zhao Yixin, the Chairman of CAMDI, delivered the greeting speech and Dr. Jiang Feng, the standing vice-chairman of CAMDI, made the work report of CAMDI in 2016. Over 300 enterprises attended the meeting and communicated their opinions on industrial development.
The Chairman Zhao Yixin delivered a greeting speech. In his speech, Zhao mentioned that 2016 was the first year of 13th Five Year Plan as well as a year to make critical development layout of medical devices industry. The issuance of Made in China 2025, 13th Five Year Plan and Outline of the National Strategy of Innovation-Driven Development and other polices will certainly promote the innovation in domestic medical devices industry to a fast development period, regulate the operation of medical devices manufacturers and bring the medical devices approval and supervision to a higher standard. Then, Zhao gave a brief introduction to the policies and regulatory environment of medical devices industry in 2017 and the future work of CAMDI in 2017.
Dr. Jiang Feng, the standing vice-chairman of CAMDI, made the work report of CAMDI in 2016. In 2016, CAMDI worked around the policy of “serving the industry, collaborating the government and improving own service” and made some achievements in all tasks under the care and guidance of competent authority and the support and cooperation of member units. By the end of 2016, the CAMDI enhanced the communication with appropriate ministries and commissions, collaborated the ministries and commissions in the propaganda, implementation and advice & feedback collection of relevant policies and regulations and made over 300 proposals. Besides, the CAMDI held nearly 100 conferences, summits, seminars and discussion meetings, including over 30 meetings above designated size. The CAMDI also established 11 new branches and enrolled 217 members. Among these, there were three focuses: firstly serving the industry and driving innovation; secondly collaborating the government and reflecting demands and thirdly improving own service and promoting industrial self-regulation. At last, Jiang made a brief summary on the work of China Strategic Alliance of Medical Device Innovation in 2016 in three aspects: guiding sci-tech innovation and strengthening project management; taking platform advantages and promoting sci-tech innovation; taking expert advantages and providing decision-making service.
In the conference, the deputy head of NDRC Price Supervision & Anti-Monopoly Bureau Li Qing made a speech titled Introduction to Fair Competition Review System. The chief of Machinery Division of MIIT Equipment Industry Department Zhao Fengjie made a speech titled Accelerating the Development of Medical Devices Industry. The director of NHDRC Medical Policy Research Office Fu Hongpeng introduced the work progress of healthcare reform. Relevant staff of Medical Insurance Department of MOHRSS Social Insurance Center gave speeches from the aspects of full-covered medical security progress and medical devices management in medical insurance.
In the morning of that day, the CAMDI also held the third meeting of 6th Council and deliberated the proposals of restructuring leader, restructuring standing directors, directors and new branches. In the meeting, Ms Xu Shan, the former deputy secretary-general, was elected as the new secretary-general by voting.
In the afternoon, the drug administration meeting was presided by Chairman Zhao Yixin, and the deputy chief of CFDA Jiao Hong, the director of Medical Device Registration Department Wang Zhexiong, the deputy director of Medical Device Supervision Department Sun Lei and the director of Center for Medical Device Evaluation Kong Fanpu were invited to attend the meeting. In the meeting, Jiao Hong made a speech and Mr. Wang Zhexiong, Mr. Sun Lei and Mr. Kong Fanpu gave their interpretations on the focuses of medical devices supervision and reform direction in 2017 which was widely concerned by medical devices manufacturers.